Hesla AC - Search Results

1

Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour.

Georgiesh T, Aggerholm-Pedersen N, Schöffski P, Zhang Y, Napolitano A, Bovée JVMG, Hjelle Å, Tang G, Spalek M, Nannini M, Swanson D, Baad-Hansen T, Sciot R, Hesla AC, Huang P, Dorleijn D, Haugland HK, Lacambra M, Skoczylas J, Pantaleo MA, Haas RL, Meza-Zepeda LA, Haller F, Czarnecka AM, Loong H, Jebsen NL, van de Sande M, Jones RL, Haglund F, Timmermans I, Safwat A, Bjerkehagen B, Boye K. Georgiesh T, et al. Among authors: hesla ac. Br J Cancer. 2022 Nov;127(10):1793-1798. doi: 10.1038/s41416-022-01959-4. Epub 2022 Aug 27. Br J Cancer. 2022. PMID: 36030294 Free PMC article.

2

Telomerase promoter mutations and copy number alterations in solitary fibrous tumours.

Lin Y, Seger N, Tsagkozis P, Hesla AC, Ghaderi M, Chen Y, Ehnman M, Warsito D, Wejde J, Larsson O, Haglund F. Lin Y, et al. Among authors: hesla ac. J Clin Pathol. 2018 Sep;71(9):832-839. doi: 10.1136/jclinpath-2018-205132. Epub 2018 Apr 27. J Clin Pathol. 2018. PMID: 29703757

3

Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years.

Hesla AC, Bruland ØS, Jebsen N, Styring E, Eriksson S, Tsagozis P. Hesla AC, et al. J Bone Oncol. 2018 Dec 26;14:100216. doi: 10.1016/j.jbo.2018.100216. eCollection 2019 Feb. J Bone Oncol. 2018. PMID: 30666289 Free PMC article.

4

An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma.

Tsagozis P, Augsten M, Zhang Y, Li T, Hesla A, Bergh J, Haglund F, Tobin NP, Ehnman M. Tsagozis P, et al. Cancer Immunol Immunother. 2019 Jun;68(6):927-936. doi: 10.1007/s00262-019-02322-y. Epub 2019 Mar 16. Cancer Immunol Immunother. 2019. PMID: 30879106 Free PMC article.

5

Transcriptome profiling of Ewing sarcomas - treatment resistance pathways and IGF-dependency.

Chen Y, Hesla AC, Lin Y, Ghaderi M, Liu M, Yang C, Zhang Y, Tsagkozis P, Larsson O, Haglund F. Chen Y, et al. Among authors: hesla ac. Mol Oncol. 2020 May;14(5):1101-1117. doi: 10.1002/1878-0261.12655. Epub 2020 Mar 13. Mol Oncol. 2020. PMID: 32115849 Free PMC article.

6

TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma.

Zhang Y, Chen Y, Yang C, Seger N, Hesla AC, Tsagkozis P, Larsson O, Lin Y, Haglund F. Zhang Y, et al. Among authors: hesla ac. Mod Pathol. 2021 Nov;34(11):2020-2027. doi: 10.1038/s41379-021-00848-0. Epub 2021 Jun 9. Mod Pathol. 2021. PMID: 34108637 Free PMC article.

7

Improved Prognosis for Patients with Ewing Sarcoma in the Sacrum Compared with the Innominate Bones: The Scandinavian Sarcoma Group Experience.

Hesla AC, Tsagozis P, Jebsen N, Zaikova O, Bauer H, Brosjö O. Hesla AC, et al. J Bone Joint Surg Am. 2016 Feb 3;98(3):199-210. doi: 10.2106/JBJS.O.00362. J Bone Joint Surg Am. 2016. PMID: 26842410

8

hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality.

Lin Y, Seger N, Chen Y, Hesla AC, Wejde J, Ghaderi M, Tsagkozis P, Larsson O, Haglund F. Lin Y, et al. Among authors: hesla ac. Mod Pathol. 2018 Dec;31(12):1834-1841. doi: 10.1038/s41379-018-0098-3. Epub 2018 Jul 31. Mod Pathol. 2018. PMID: 30065261 Free article.

9

Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.

Brodin BA, Wennerberg K, Lidbrink E, Brosjö O, Potdar S, Wilson JN, Ma L, Moens LN, Hesla A, Porovic E, Bernhardsson E, Papakonstantinou A, Bauer H, Tsagkozis P, von Sivers K, Wejde J, Östling P, Kallioniemi O, Stragliotto CL. Brodin BA, et al. Br J Cancer. 2019 Feb;120(4):435-443. doi: 10.1038/s41416-018-0359-4. Epub 2019 Feb 12. Br J Cancer. 2019. PMID: 30745580 Free PMC article.

10

Subsequent primary neoplasms among bone sarcoma survivors; increased risks remain after 30 years of follow-up and in the latest treatment era, a nationwide population-based study.

Hesla AC, Discacciati A, Tsagkozis P, Smedby KE. Hesla AC, et al. Br J Cancer. 2020 Apr;122(8):1242-1249. doi: 10.1038/s41416-020-0748-3. Epub 2020 Feb 18. Br J Cancer. 2020. PMID: 32066914 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page